The Europe C-Arms Market would witness market growth of 4.6% CAGR during the forecast period (2022-2028).
Healthcare practitioners can expand beyond task-specific applications with the help of new technology and breakthroughs in picture identification with deep learning algorithms. Many hospital applications have found artificial intelligence (AI) useful tools. AI technology can review medical imaging options to identify the best treatment for serious body problems. The diagnostic and imaging quality of the patient is also greatly enhanced by the development of AI-powered imaging technologies.
This new technology opens prospects to provide a detailed image view with a lower radiation dose per image. As a result, adding artificial intelligence (AI) to radiology in medical equipment aids in enhancing operational effectiveness and patient outcomes, fueling an overall increase in demand for C-Arm devices.
C-Arm systems are becoming a crucial instrument in contemporary surgical practice for intraoperative treatments. Lowering morbidity and patients' length of hospital stay (LOS) also improves the surgeon's technical proficiency. The C-Arm's robust imaging system enables several movements to be carried out in a single session. C-Arm machines are frequently used in therapeutic investigations like needle or stent placements and in urology, pain management, and emergencies.
More than 50 million people in Europe suffer from multiple chronic diseases, whether due to a synergistic progression of the diseases, similar underlying risk factors, or simply coincidental co-occurrence. With the number and mix of comorbidities, the expenses associated with treating and caring for persons with multiple illnesses continue to rise dramatically. Major illness diagnosis has become more challenging as a result. This has prompted regional governments to lay out funds and initiatives to lower the burden of such severe health issues. These developments include the adoption of technologically advanced diagnostic tools for early diagnosis. Therefore, the market will expand in the coming years due to the aforementioned factors.
The Germany market dominated the Europe C-Arms Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $178.8 Million by 2028. The UK market is anticipated to grow at a CAGR of 3.7% during (2022 - 2028). Additionally, The France market would display a CAGR of 5.4% during (2022 - 2028).
Based on End User, the market is segmented into Hospitals, Diagnostic Centers and Specialty Clinics. Based on Type, the market is segmented into Mobile and Fixed. Based on Application, the market is segmented into Orthopedic & Trauma, Oncology, Cardiology, Gastroenterology, Neurology and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
Free Valuable Insights: The Worldwide C-Arms Market is Projected to reach USD 2.7 Billion by 2028, at a CAGR of 5%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Canon, Inc. (Canon Medical Systems Corporation), Siemens Healthineers AG (Siemens AG), Koninklijke Philips N.V., GE HealthCare Technologies, Inc., Fujifilm Holdings Corporation, Shimadzu Corporation, Hologic, Inc., Ziehm Imaging GmbH, Trivitron Healthcare Pvt. Ltd., and Nanjing Prelove Medical Equipment Co., Ltd.
By End User
By Type
By Application
By Country
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
